<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
51662-1409-3
</NDCCode>
<PackageDescription>
25 POUCH in 1 CASE (51662-1409-3) / 1 VIAL in 1 POUCH (51662-1409-2) / 5 mL in 1 VIAL
</PackageDescription>
<NDC11Code>
51662-1409-03
</NDC11Code>
<ProductNDC>
51662-1409
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Heparin Sodium
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Heparin Sodium
</NonProprietaryName>
<DosageFormName>
INJECTION, SOLUTION
</DosageFormName>
<RouteName>
INTRAVENOUS; SUBCUTANEOUS
</RouteName>
<StartMarketingDate>
20191111
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
NDA
</MarketingCategoryName>
<ApplicationNumber>
NDA017029
</ApplicationNumber>
<LabelerName>
HF Acquisition Co LLC, DBA HealthFirst
</LabelerName>
<SubstanceName>
HEPARIN SODIUM
</SubstanceName>
<StrengthNumber>
10000
</StrengthNumber>
<StrengthUnit>
[USP'U]/mL
</StrengthUnit>
<Pharm_Classes>
Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2024-01-31
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20221110
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>